Supermicro to be Added to S&P MidCap 400® Index
SAN JOSE, Calif.–(BUSINESS WIRE)–Supermicro (Nasdaq: SMCI), a Total IT Solution Provider for Cloud, AI/ML, Storage,…
Month: December 2022
CyberArk Appoints Omer Grossman Global Chief Information Officer
With his lengthy military career, Grossman brings strong cloud infrastructure and cybersecurity resiliency experience to…
Dialpad Commits $50M in AI R&D to Fuel Business Insights and Launch Dialpad Ai Labs
Investment over the next five years will transform employee, agent, and customer experiences Dialpad Ai…
Advocado Taps Corporate Leaders to Help Build Industry Strategies and Partnerships
Yahoo and Sony veterans Scott Garner, Jaime Siegel and Brian Siegel join the premier data-first…
Fusion Risk Management Appoints Edna Conway to Board of Directors
Renowned security expert will leverage her extensive expertise to support Fusion’s continued growth CHICAGO &…
ISG to Publish Report on Digital Engineering Services
Upcoming ISG Provider Lens™ report will evaluate providers enabling faster and more predictable product development,…
Over 70% of Millennials Ready to Switch Banks for Better Savings APY, M1 Survey Finds
Only half of US Millennials think their primary financial institution will help them meet their…
Cabot Corporation Announces Executive Leadership Promotions
BOSTON–(BUSINESS WIRE)–Cabot Corporation (NYSE: CBT) is pleased to announce the promotions to Executive Vice President…
J.D. Power – LMC Automotive U.S. Automotive Forecast for December 2022
Up, Up and Up in December: New-Vehicle Sales Increase, Transaction Prices Hit Record High and…
Slate Asset Management Announces Partner and Managing Director Promotions
TORONTO–(BUSINESS WIRE)–Slate Asset Management (“Slate”), a global alternative investment platform targeting real assets, today announced…
Israel- Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute
U.S. Patent and Trademark Office extends protection of Clearmind’s proprietary MEAI and expands its potential…
Y-mAbs Announces Partnership Regarding Early Access Program for DANYELZA (naxitamab-gqgk) in Europe
NEW YORK, Dec. 21, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Update on First BioNTainer for African-based mRNA Manufacturing Facility
MAINZ, GERMANY, December 21, 2022 — BioNTech SE (Nasdaq: BNTX, “BioNTech”) reached the next milestone…
Healthy Extracts’ Whitney Johns Brain Activate ENERGY Gel Packs Now Available on Amazon.com
Brain Activate – ENERGY Gel Brain Activate – ENERGY Gel is a rapidly absorbed focus…
Sofwave Market Approvals For SUPERB™ Non-Invasive Wrinkle Reduction Technology Now Extend to Taiwan
Taiwan’s Food and Drug Administration, Division of Medical Devices and Cosmetics, grants Sofwave regulatory approval…
Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI
LEXINGTON, Mass., Dec. 21, 2022 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company…
Aerami Therapeutics Announces Completion of Dosing in Phase 1 Trial of AER-901 (inhaled imatinib), a Critical Milestone Toward the Planned Initiation of a Phase 2 Trial in Pulmonary Arterial Hypertension (PAH) During the First Half of 2023
AER-901 (inhaled imatinib), a potential reverse-remodeling therapy, is being developed to address unmet need for…
Vir Biotechnology Achieves Target Enrollment for Groundbreaking Phase 2 PENINSULA Trial Evaluating VIR-2482 for Prevention of Seasonal Influenza A
– Approximately 3,000 participants enrolled with initial trial data expected in mid-2023 – SAN FRANCISCO,…
Agios to Present at 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
CAMBRIDGE, Mass., Dec. 21, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader…
Aerami Therapeutics Appoints Lisa Yañez as Chief Executive Officer
Ms. Yañez brings deep category experience and will lead Aerami’s focus on cardiopulmonary disease as…